Filing Details
- Accession Number:
- 0001144204-18-059492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-13 21:40:33
- Reporting Period:
- 2018-11-08
- Accepted Time:
- 2018-11-13 21:40:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
727207 | Accelerate Diagnostics Inc | AXDX | Laboratory Analytical Instruments (3826) | 841072256 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1021413 | John Patience | 28161 N. Keith Drive Lake Forest IL 60045 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-11-08 | 10,000 | $14.96 | 39,411 | No | 4 | P | Indirect | By John Patience Defined Benefit Pension Plan |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By John Patience Defined Benefit Pension Plan |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,191,211 | Indirect | By John Patience Trust dated 7/23/1993 |
Common Stock | 2,110,662 | Indirect | By Patience Enterprises LP |
Common Stock | 44,670 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.96 to $15.00, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc., any shareholder of Accelerate Diagnostics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the range.
- The reporting person disclaims beneficial ownership of these securities except in the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.